Wearable Movement Sensors for Assessing Motor Impairments and Dyskinesias in Parkinson Disease

University of Rochester1 site in 1 country12 target enrollmentJanuary 2012

ConditionsParkinson Disease

Overview

Phase: N/A
Intervention: Not specified
Conditions: Parkinson Disease
Sponsor: University of Rochester
Enrollment: 12
Locations: 1
Primary Endpoint: 1-3Hz gyroscope signal power
Status: Completed
Last Updated: 2 years ago

Overview Investigators Eligibility Criteria Outcomes Sites Similar Trials

Overview

Brief Summary

The purpose of this study is to measure motor fluctuations and dyskinesias in patients with Parkinson's disease using movement sensors (accelerometers and gyroscopes) to determine if this is a feasible measure to use in addition to self report, and eventually the goal will be to replace self report with a more reliable measure such as movement sensors.

Detailed Description

Patients with Parkinson disease and motor fluctuations will wear movement sensors during their regular clinic visit with the principal investigator. The visit will be videotaped and medication status (ON without dyskinesia, ON with dyskinesia, or OFF) will be independently rated from review of the video.

Registry

clinicaltrials.gov

Start Date

January 2012

End Date

June 2013

Last Updated

2 years ago

Study Type

Observational

Sex

All

Investigators

Sponsor

University of Rochester

Responsible Party

Sponsor

Eligibility Criteria

Inclusion Criteria

•Participants who will be included in the study have probable or definite idiopathic PD (CAPSIT criteria (23)), Hoehn \& Yahr stage 2-4;
•One or more of the following PD-associated motor impairments experienced in the week prior to enrollment (based on history and/or examination): motor fluctuations (end of dose wearing off with hypokinesia and/or levodopa-induced choreiform dyskinesias), tremor, freezing of gait, or frequent falls (≥ 1 per week).

Exclusion Criteria

•Neurological disorders (other than PD) or orthopedic deficits that, in the investigator's judgement, contribute substantially to impaired movement (e.g. stroke with motor sequelae;
•Essential tremor;
•Severe osteoarthritis);
•Cognitive impairment sufficiently severe to interfere with informed consent.